Oral ONC201 in Adult Recurrent Glioblastoma
Clinical trial NCT02525692 · TERMINATED
Trial details
- NCT number
- NCT02525692
- Sponsor
- Jazz Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2023-04-17
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.